aod9604 phase 2b trial results weight loss AOD 9604: Peptide Claims vs Clinical Reality, AOD 9604 is marketed as a fat-metabolism peptide derived from a growth hormone fragment, often positioned as “HGH-like” without HGH’s side effects. The Peptide Series: What to Know
Description
1 Critically, and in contrast to chronic treatment with intact hGH, AOD-9604 had no adverse effect on insulin sensitivity as measured by euglycemic clamp the experimental result that anchors the compounds central selling point of lipolysis-without-diabetogenic-cost
A brief consultation is required to ensure the injection is suitable and safe for you
If done properly the injection will barely be felt
Generally, it is regarded as: an investigational research compound
Orders over $150 qualify for free standard US shipping
